VAMG
RPRX icon

Voisard Asset Management Group’s Royalty Pharma RPRX Stock Holding History

Voisard Asset Management Group’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17
Closed -$481 – 539
2024
Q3 		$481 Buy
+17
New +$471 ﹤0.01% 600

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Voisard Asset Management Group's RPRX Position: Q4 2024 in Review

Voisard Asset Management Group sold out of Royalty Pharma (RPRX) in Q4 2024, closing a stake of 17 shares — an estimated $481 sold.

Voisard Asset Management Group first reported a position in RPRX in Q3 2024 and held it in 1 quarter. The position peaked at $481 in Q3 2024. 417 funds tracked by Wall St. Rank hold RPRX as of Q4 2024.

  • Voisard Asset Management Group reported no remaining Royalty Pharma position as of Q4 2024 after selling out during the quarter.
  • Voisard Asset Management Group sold 17 Royalty Pharma shares in Q4 2024, an estimated $481.
  • Voisard Asset Management Group first reported a position in Royalty Pharma in Q3 2024 and held it in 1 quarter.
  • Voisard Asset Management Group's Royalty Pharma position peaked at $481 in Q3 2024.
  • 417 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2024.

Based on Voisard Asset Management Group's 13F filing for Q4 2024, filed 7 Feb 2025.